LEO Pharma Reveals U.S. Chronic Hand Eczema Data
October 24, 2025
The CHECK study, a cross-sectional survey of over 10,000 participants, is the first to quantify the prevalence of chronic hand eczema (CHE) in the U.S.
The CHECK study, a cross-sectional survey of over 10,000 participants, is the first to quantify the prevalence of chronic hand eczema (CHE) in the U.S.
Welcome to your Daily Dose of Health Tech Innovation!Stay ahead with the latest breakthroughs revolutionizing healthcare—from AI diagnostics to remote care solutions.We bring you expert-curated insights,
Funding accelerates advancement of AngioAI+, the company’s investigational AI-based platform for diagnosing CAD and CMD. AngioInsight, a leader in AI-powered cardiovascular diagnostics, announced the appointment of Shlomi
– New Three-Year Interim Data Demonstrates Livdelzi May Help Stabilize or Improve Liver Health in PBC Patients – Gilead Sciences, Inc. will present new research that
Vertex Pharmaceuticals Incorporated announced the presentation of multiple abstracts demonstrating the clinical benefits of treatment with CFTR modulators, including the Company’s most recently approved medicine, ALYFTREK,
BluHaven Health Infusion Center is proud to announce the grand opening of its first location, based in Raleigh. The infusion center provides patients with safe,
US Acute Care Solutions (USACS), the nation’s largest physician-owned emergency and inpatient medicine practice, is proud to announce the launch of the Journal of Acute
eClinicalWorks, the largest ambulatory cloud EHR, announced the successful integration of Sunoh.ai, the EHR-agnostic AI medical scribe across Florida-based Suncoast Community Health Centers locations. The AI medical transcription
Medison, the global biopharmaceutical company known for its unified commercialization platform that helps deliver breakthrough therapies to international markets, has announced the appointment of Francis
Alife Health, a health tech company advancing the future of fertility care with artificial intelligence, announced that Embryo Predict, its AI-powered embryo selection tool, has
Apotex, the largest Canadian-based pharmaceutical company, announced that Health Canada has granted a Notice of Compliance (NOC) for LOQTORZI for the treatment of nasopharyngeal carcinoma
L-Nutra, the global leader in longevity and medical nutrition science, announced the launch of the Prolon Guided Health Program for Weight and Metabolic Wellness, the